|Videos|April 24, 2017

What Are the Consequences of Prescribing Unnecessary Antibiotics?

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses the potential consequences of prescribing unneeded antibiotics.

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses the potential consequences of prescribing unneeded antibiotics.

Interview Transcript (slightly modified for readability)

“I would say that there are potential [unfortunate] consequences of prescribing antibiotics when they’re not needed. We know that antibiotics have great benefit when they’re needed, but when they’re not needed, there are potential adverse events.

Some of those include very mild events or very mild side effects, like diarrhea [or] rash, but they could be more severe, like a severe allergic reaction or anaphylaxis, which can be life-threatening. Then, one of the more common adverse events that we’re really concerned about, especially in dentistry, is Clostridium difficile infections; it is a potentially deadly form of diarrhea and we see it very frequently with certain antibiotics like Clindamycin, which is a common antibiotic used in dentistry. So, even one dose of an antibiotic that’s not needed could potentially lead to a severe outcome.”


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.